Targeted reminders increase serious illness conversations in cancer care
New research in the June 2026 issue of JNCCN-Journal of the National Comprehensive Cancer Network finds that small, targeted prompts…
Parkinson’s drug may ease anhedonia in treatment-resistant depression
For many people who suffer from depression, the condition is not just about feeling down, but also about…
The Liver Doc on his fight against pseudoscience, wellness myths and powerful interests
A 14-year-old girl walks into his ward with severe liver damage. The culprit? Traditional herbal medicine sold freely…
Apitegromab helps tirzepatide users lose fat while preserving lean mass
A phase 2 trial suggests that blocking myostatin activation may help people taking tirzepatide retain more lean body…
Common joint supplement may accelerate Alzheimer’s disease progression
New research has found an association between taking glucosamine, a popular over-the-counter supplement used for joint pain, and…
New project launches to advance chikungunya vaccine in Africa
Funded by the Global Health EDCTP3 Joint Undertaking, a new €15.3 million project coordinated by Institut Pasteur brings…
Exercise during pregnancy links to lower infant BMI at one year
Mothers who followed a supervised exercise program throughout pregnancy had babies with lower BMI and reduced odds of…
‘Cancer Bush’ shows promise as complementary medicine to chemotherapy
A plant found across South Africa and long used in traditional medicine could one day help fight some…
An experimental GLP-1 pushes the limits of weight loss. There are risks.
Eli Lilly this month unveiled startling new data that showed an experimental weight-loss drug caused people with obesity…
Implanted collagen tiles double survival for brain metastasis patients
A multicenter clinical trial led by researchers at The University of Texas MD Anderson Cancer Center has found…
WHO prioritizes candidate vaccines and therapeutics for Bundibugyo virus
In response to the current outbreak of Ebola disease caused by Bundibugyo virus occurring in the Democratic Republic…
Ocrelizumab slows disability progression in advanced progressive multiple sclerosis
A major international phase III clinical trial, led by Queen Mary University of London, has found that ocrelizumab…